Description :
Tenders for Short Term E-bid For Rate Contract Cum Supply And Empanelment Of Firms For Drugs And Medicines - Fluorouracil Inj Ip 250 Mg/ 5ml [148], Mercaptopurine Tablets Ip 50 Mg [152], Methotrexate Tab Ip 2.5 Mg [154], Vincristine Injection Ip 1 Mg [159], Atropine Eye Ointment Ip 1% [319], Ciprofloxacin Ophthalmic Ointment Usp 0.3% [323], Dacarbazine Injection 500 Mg Ip [529], Inj. Ganciclovir Sodium 500mg (lyophilized Powder For Reconstitution) [724], Recombinant F Ix 500 Iu With Diluent [748], 3rd Generation Recombinant F Viii 250 Iu With Diluent [749], Brinozolamide 1% W/v And Brimonidine Tartrate 0.2% W/v Ophthalmic Suspension [nrd-98], Gatifloxacin 0.30% And Prednisolone Acetate 1% Ophthalmic Suspension [nrd-103], Hpmc 0.3% Eye Drop [nrd-104], Proparacaine 0.5% W/v Eye Drop Usp [nrd-114], Voriconazole 1 % W/v (lyophilized) 30mg Eye Drop [nrd-119], Chloramphenicol 1%, Polymyxin B Sulphate (10000 Units) And Dexamethasone 0.1% Sodium Phosphate Eye Ointment [nrd-123], Cabazitaxel Injection 60 Mg [nrd-167], Carmustine 100 Mg Inj. Ip [nrd-175], Fludarabine Phosphate Injection 100mg Inj. Ip [nrd-237], Fludarabine Phosphate Injection 50mg Inj. Ip [nrd-238], Methotrexate 1000 Mg Inj. Ip [nrd-289], Inj. Methylprednisolone Acetate 125 Mg I.p. (each Vial Contains Methylprednisolone Acetate 125 Mg) [nrd-292], Mitomycin 40 Mg Inj. Ip [nrd-297], Omalizumab 150 Mg Vial Inj. [nrd-321], Plerixafor 24 Mg Inj. [nrd-338], Rasburicase 1.5 Mg Inj. [nrd-347], Recombinant Lh 75iu Inj. [nrd-351], Trabectedin 1 Mg Inj. [nrd- 387], Everolimus 5mg Tab./cap. [nrd-530], Everolimus 10mg Tab./cap. [nrd-531], Eltrombopag 25mg Tablet / Capsule [nrd-617], Eltrombopag 50mg Tablet / Capsule [nrd-618], Nilotinib 150 Mg Tablet / Capsule [nrd-710], Nilotinib 200 Mg Tablet / Capsule [nrd-711], Regorafenib 40 Mg Tab. [nrd-757], Tegafur 100mg And Uracil 224mg Capsule [nrd-794], Ulipristal 5mg Tab. [nrd-808], Glycopegylated Extended Half Life Factor Viii 1000 Iu
